Should industry sponsor research?
Opinions are divided on whether research and educational material funded by the tobacco, alcohol, or infant formula industries can be scientifically sound or whether it is inevitably tainted. Here, doctors, researchers, and a member of a pressure group argue the pros and cons.
Tobacco industry research: collaboration, not confrontation, is the best approach
- Christopher J Proctor (Christopher_Proctor@britamtob.com)
- British American Tobacco, Millbank, Knowle Green, Staines, Middlesex TW18 1DY
- University of Essex, Wivenhow Park, Colchester CO4 3SQ
- Fletcher School of Law and Diplomacy, Tufts University, Medford, MA 02155, USA
- Addiction
- MRC Childhood Nutrition Research Centre, Institute of Child Health, London WC1N 1EH
- Baby Milk Action, 23 St Andrew's Street, Cambridge CB2 3AX
Editorial by Smith Letters(p 344 Filler (p 318 News (p 301
Smoking is strongly associated with several diseases, sufficiently so for public health authorities to say that smoking is a cause of disease and to have warned the public for many years of the dangers of smoking. British American Tobacco respects these actions. Yet science has still to ascertain precise biological mechanisms whereby prolonged exposure to constituents of tobacco smoke causes these diseases. Science has also yet to determine why, for most diseases associated with smoking, the overwhelming majority of lifetime smokers do not contract the diseases, and why there are geographical differences in the incidence of many diseases that are related to smoking.
The public health conclusion that smoking is a cause of disease can lead to two quite different approaches. One approach determines that nothing can be gained from a greater understanding of the relation between smoking and disease, that no one should smoke, and that all efforts should focus on persuading people not to smoke. The second approach continues to persuade people not to smoke but accepts that smoking is a popular custom and seeks to discover more about the association between smoking and various diseases in order to determine what changes to tobacco products might be introduced to reduce the risks associated with smoking.
Historically, British governments have taken the second approach, working with tobacco companies and supporting the funding of biomedical research related to tobacco modification. This has led to a greater understanding of smoking behaviour, constituents of smoke, and possible mechanisms …
Sign in
Article access
Article access for 1 day
Purchase this article for £20 $30 €32*
The PDF version can be downloaded as your personal record
CiteULike
Connotea
Del.icio.us
Digg
Facebook
Mendeley
Reddit
Technorati
Twitter
Stumbleupon
Rapid responses
Latest Responses
Re: Venous thrombosis in users of non-oral hormonal contraception: follow-up study, Denmark 2001-10
Published 16 May 2012
Re: Outcomes of elective induction of labour compared with expectant management: population based study
Published 16 May 2012
Re: Outcomes of elective induction of labour compared with expectant management: population based study
Published 16 May 2012
Re: Why the US healthcare system is failing, and what might rescue it
Published 16 May 2012
Re: Risk of cardiovascular serious adverse events associated with varenicline use for tobacco cessation: systematic review and meta-analysis
Published 16 May 2012
Most responses
What are the benefits of an early diagnosis? (8 responses)
Published 18 Apr 2012
The psychiatric oligarchs who medicalise normality (8 responses)
Published 2 May 2012
Are doctors justified in taking industrial action in defence of their pensions? No (8 responses)
Published 8 May 2012 - 12:21
Are doctors justified in taking industrial action in defence of their pensions? Yes (8 responses)
Published 8 May 2012 - 12:21
Streptococcus B in pregnancy: to screen or not to screen? (7 responses)
Published 18 Apr 2012 - 13:53